Atrys Health Overview
- Year Founded
-
2007
- Status
-
Public
- Employees
-
1,985
- Stock Symbol
-
ATRY
- Investments
-
21
- Share Price
-
$2.69
- (As of Friday Closing)
Atrys Health General Information
Description
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.
Contact Information
Website
www.atryshealth.comCorporate Office
- Calle Velázquez 157, 4ºA
- 28002 Madrid
- Spain
Corporate Office
- Calle Velázquez 157, 4ºA
- 28002 Madrid
- Spain
Atrys Health Stock Performance
As of 20-Nov-2026, Atrys Health’s stock price is $2.69. Its current market cap is $204M with 75.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.69 | $2.80 | $2.59 - $3.75 | $204M | 75.9M | 39.8K | -$1.50 |
Atrys Health Financials Summary
As of 30-Jun-2026, Atrys Health has a trailing 12-month revenue of $172M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 499,203 | 539,245 | 513,651 | 571,790 |
| Revenue | 172,271 | 159,057 | 140,648 | 218,113 |
| EBITDA | (16,048) | (11,914) | 17,876 | 30,728 |
| Net Income | (113,611) | (113,135) | (34,383) | (49,332) |
| Total Assets | 360,373 | 580,310 | 607,896 | 695,298 |
| Total Debt | 135,227 | 302,894 | 265,760 | 280,772 |
Atrys Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Atrys Health Patents
Atrys Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2634254-T3 | Methods for prognosis of diffuse large b lymphocyte lymphoma | Active | 12-Sep-2011 | ||
| EP-2568290-A1 | Methods for prognosis of diffuse large b-cell lymphoma | Active | 12-Sep-2011 | ||
| EP-2568290-B1 | Methods for prognosis of diffuse large b-cell lymphoma | Active | 12-Sep-2011 | G01N33/57505 |
Atrys Health Signals
Atrys Health Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Atrys Health Investments & Acquisitions (21)
Atrys Health’s most recent deal was a Merger/Acquisition with Chaxa Radiology. The deal was made on 14-Jun-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Chaxa Radiology | 14-Jun-2023 | Merger/Acquisition | Other Business Products and Services | ||
| Grupo SOHIN(Cuidarte clinics) | 09-Jan-2023 | Corporate Asset Purchase | Buildings and Property | ||
| Initia Oncologia | 28-Dec-2022 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Chilerad | 27-Dec-2022 | Merger/Acquisition | Diagnostic Equipment | ||
| Bienzobas | 13-Jun-2022 | Merger/Acquisition | Clinics/Outpatient Services |
Atrys Health ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Services
Subindustry
Rank
Percentile
Atrys Health Exits (1)
Atrys Health’s most recent exit was on 21-Apr-2021 from Aspy Global Services. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Aspy Global Services | 21-Apr-2021 | Completed |
|
Atrys Health Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Genetyca-ICM | Porto, Portugal | 2018 | |
| SIMM Molecular | Barcelona, Spain | 2017 | |
| Bienzobas | Almeria, Spain | 2000 | |
| IMOR Institute | Barcelona, Spain | 1999 | |
| Initia Oncologia | Valencia, Spain |
Atrys Health FAQs
-
When was Atrys Health founded?
Atrys Health was founded in 2007.
-
Where is Atrys Health headquartered?
Atrys Health is headquartered in Madrid, Spain.
-
What is the size of Atrys Health?
Atrys Health has 1,985 total employees.
-
What industry is Atrys Health in?
Atrys Health’s primary industry is Other Healthcare Services.
-
Is Atrys Health a private or public company?
Atrys Health is a Public company.
-
What is Atrys Health’s stock symbol?
The ticker symbol for Atrys Health is ATRY.
-
What is the current stock price of Atrys Health?
As of 20-Nov-2026 the stock price of Atrys Health is $2.69.
-
What is the current market cap of Atrys Health?
The current market capitalization of Atrys Health is $204M.
-
What is Atrys Health’s current revenue?
The trailing twelve month revenue for Atrys Health is $172M.
-
What is Atrys Health’s annual earnings per share (EPS)?
Atrys Health’s EPS for 12 months was -$1.50.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process